Authors


Ed Cohen, PharmD, FAPhA

Latest:

Pharmacy’s Role in Public Health Initiatives

Panelists share final thoughts and advice regarding the critical role pharmacy has played and continues to play in public health initiatives.


Jola Mehmeti, PharmD Candidate

Latest:

A Brief Look at the Clinical Uses of N-Acetylcysteine

N-Acetylcysteine has several clinical uses. These include detoxification in acetaminophen overdose and improving outcomes in COPD exacerbations.


Françoise Pradel, PhD

Latest:

Payers' Views on the Heterogeneity of Treatment Effect in Oncology

When making coverage decisions in oncology, payers find difficulties in translating evidence on treatment effect heterogeneity into coverage policies.



Blerina Mukallari, PharmD Candidate

Latest:

Community Pharmacists: Valuable Team Members in the Fight with Diabetes

Through clinical and humanistic interventions, pharmacists can improve outcomes and lower costs for patients with diabetes.


Jennifer Whartenby, Senior Managing Editor

Latest:

Putting Classroom Learning to the Test

McKaya Schmit guided patients through a natural disaster.


Brianne Molnar, Kara Patterson, & Jonathan Ogurchak, PharmD, CSP

Latest:

Utilizing Medication Aids to Improve Adherence in Transplant Patients

Patients who have received a transplant and are non-adherent to their medication regimens are more likely to experience graft failure and higher health care costs.



Jordan J. Spurling

Latest:

OTC Hearing Aids Offer Opportunities for Pharmacists

2017 Law Gives Pharmacies Ability to Help Patients Select and Adjust Devices



Dominic Pilon, MA

Latest:

Direct and Indirect Cost Burden of Chronic Hepatitis C

An estimation of the direct healthcare and indirect work-loss cost burden of chronic HCV using health insurance claims covering 13 million individuals.


Henry J. Henk, PhD

Latest:

Costs Associated With Second-Line Therapies for Lung Cancer

Erlotinib may confer an economic advantage for payers over docetaxel and pemetrexed for second-line treatment of lung cancer because of lower costs.


Joseph J. Doyle, MBA, RPh

Latest:

Value-Based Benefit Design and Healthcare Utilization in Asthma, Hypertension, and Diabetes

A value-based benefit design program for prescription medications for asthma, hypertension, and diabetes could result in increased prescription use and decreased healthcare utilization and costs.


Danny Gavord, PharmD Candidate

Latest:

Bispecific Antibodies: The Next Generation of Immunotherapy

Advances in biotechnology have improved the production and recombination of antibodies, leading to improvements in monoclonal antibody therapies.



Danielle Candelario, PharmD

Latest:

The Role of the Pharmacist in Improving Outcomes in Patients Using Contact Lens Cleaning Solutions

Pharmacists can learn about issues relating to the use of contact lens cleaning solutions.


Aldo Alvarez-Risco, MSc, Mg, BPharm

Latest:

Web Exclusive: Pharmacists and Mass Communication for Implementing Pharmaceutical Care

Pharmacists' communication activities are critical to improving and maintaining a positive image among the public; therefore, a media plan should be in place in order to reach both broad and narrowly defined audiences.


George L. Bakris, MD

Latest:

Implementing Guideline-Recommended Therapy for Patients With CKD: Is Hope on the Horizon?

This commentary addresses the possible reasons for treatment gaps between recommended therapy for patients with CKD, and the realities of current practices, and examines new developments that may bridge the gap.


Tyler Pitcock, PharmD Candidate

Latest:

Medication Synchronization Laws Can Improve Adherence

Some states are considering and enacting legislation for programs aligning patients’ refill schedules.


Katherine Carey, PharmD

Latest:

Continuity of Care: Diabetic Neuropathy: Bridging the Sensation Gap

Pharmacists in all health care settings play an important role in the prevention and treatment of diabetic neuropathy.




Stephen C. Howell, PharmD Candidate

Latest:

Creating Your Brand as a Future Health Care Provider

What do you imagine when you hear the word “brand”?


Lindsey B. Kays, PharmD Candidate

Latest:

Advancements Come With a Cost: Oral Chemotherapy Parity Laws

Pharmacy is a service profession in which we have the utmost responsibility to improve outcomes, lower cost, and improve the quality of life for patients with all types of health conditions.


George Shrady, MS

Latest:

Pregabalin Prior Authorization and Potential Medication-Medication and Medication-Condition Interactions

This study of patients treated with pregabalin or duloxetine found that pregabalin prior authorization policies were associated with increased exposure to potential medication-medication and medication-condition interactions.


Caitlyn Fitzpatrick

Latest:

How HIV Can Infect Macrophages

Even macrophages aren’t safe from HIV.


Rebecca L. Bigler, PhD, at Therapeutic Genetics Consulting Associates

Latest:

Pharmacogenomics for Precision Specialty Pharmacy Care

Personalized precision medical care addresses as many unique characteristics of the patient as possible.


Bryan Schuessler, PharmD, MS

Latest:

Building the Case for Integrated Care With Specialty Pharmacy in Health Systems

Specialty pharmacies are the primary provider of oncology-related medication therapy.


Carmen Gust, PharmD Candidate 2019

Latest:

Learning from a Distance

As the wife of a collegiate basketball coach, I have lived in 7 states over 8 years; moving is simply a part of the game.


Vu H. Duong, MD, MS

Latest:

Utilization Impacts of New Oral Substitutes for Parenteral Cancer-Related Therapies

Examination of changes in utilization, dose adequacy, and duration associated with market entry of the oral chelator deferasirox as a potential substitute for parenteral deferoxamine.